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Natural products provide many bioactive lead molecules for the discovery of 
new medicines. Naturally, derived phytochemicals have exhibited tremendous 
biological activities including anticancer activity. More than 60% of antitumor 
medicines are closely associated with natural products. In the present study, hexane, 
chloroform, acetone and methanol extracts from roots of Moringa peregrina were 
screened for phytochemical analysis and anticancer activity. Phytochemical 
analysis was performed by Gas Chromatography and Mass spectrometry (GC-MS). 
The anticancer potential of the extracts was done on the human breast cancer cell 
line (MCF-7) and cell viability was measured using WST-1 Cell Proliferation Assay 
Kit. The cell line was treated with different concentrations (10, 20, 40, 80, 160 and 
320 µg/ml) of plant extracts and the results were compared with the standard drug 
Doxorubicin. The results of GC-MS analysis of different extracts revealed the 
presence various compounds. The anticancer studies revealed that the chloroform 
extract of M. peregrina have good activity against the human breast cancer cell line 
with the IC50 value of 127.38 µg/ml. The IC50 values of hexane, acetone and 
methanol extracts were 315.0, 284.8 and 353.10 µg/ml respectively. Whereas the 
IC50 value of the standard drug, Doxorubicin was 25.88 µg/ml. Based on these 
results, further study is warranted for the isolation of anticancer molecule from 
chloroform extract of M. peregrina root tubers.  
 
Keywords: Natural products, Moringa peregrina, phytochemical analysis, GC-MS, 







Title and Abstract (in Arabic) 
 
 (.Moringa peregrina (Forssk لمستخلصات جذور المورینغا تقییم التركیب الكیمیائي
Fiori  على مكافحة السرطان واحتمالیة القدرة 
 
 الملخص
جدیدة. وبطبیعة أدویة الى اكتشاف  تؤديالمركبات الحیویة التي توفر المنتجات الطبیعیة العدید من 
تھا الھائلة في االنشطة شتقة من منتجات طبیعیة على فاعلیالحال، أظھرت المركبات الكیمیائیة النباتیة الم
٪ من األدویة المضادة لألورام بشكل وثیق  60مضادات لمرض السرطان. ترتبط أكثر من البیولوجیة كعملھا ك
المركبات الكیمیائیة النباتیة وفاعلیتھا في مكافحة السرطان  مع المنتجات الطبیعیة. في ھذه الدراسة، تم تقییم
الھكسان والكلوروفورم واألسیتون  مثل المورینجا بواسطة مذیبات مختلفة المستخلصة من جذور نبات
 والمیثانول.
). تم GC-MSتم إجراء التحلیل الكیمیائي النباتي بواسطة التحلیل الكروماتوجرافي والطیف الكتلي (
) وتم قیاس قابلیة حیویة الخلیة MCF-7قدرة المستخلصات المضادة للسرطان على خالیا سرطان الثدي ( تقییم
بتركیزات مختلفة  المصابة بالسرطان . تم معاملة الخلیةWST-1 Cell Proliferation Assay Kitباستخدام 
وتمت مقارنة النتائج مع میكروغرام / مل) من المستخلصات النباتیة  320و  160،  80،  40،  20،  10(
 عقار دوكسوروبیسین القیاسي.
مركبات. بینت الدراسات عدة مختلفة على وجود المستخلصات لل GC-MSكشفت نتائج تحلیل 
البالغة  50ICالمضادة للسرطان أن مستخلص الكلوروفورم لھ نشاط جید ضد خالیا سرطان الثدي البشري بقیمة 
و  284.8و  315.0لمستخلصات الھكسان واألسیتون والمیثانول  50ICمیكروغرام / مل. كانت قیم  127.38
للدواء القیاسي ( عقار دوكسوروبیسین)  50ICمیكروغرام / مل على التوالي. في حین أن قیمة  353.10
راء دراسة لعزل المركب المضاد إج حاجة الىھناك فمیكروغرام / مل. استنادا إلى ھذه النتائج،  25.88
 الكلوروفورم. مستخلصللسرطان في مستخلص جذور نبات المورینجا الذائب في 
 
مضادات ، فاعلیة  GC-MSالمنتجات الطبیعیة، نبات المورینغا، التحلیل الكیمیائي النباتي،  الكلمات المفتاحیة:
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Chapter 1: Introduction 
 
1.1 Overview 
Cancer is a generic term that can affect any part of the body by the quick 
formation of irregular cells that grow beyond its normal boundaries and which can then 
affect adjoining parts of the body later that leads to death (WHO, 2018). Globally, 
cancer is the second leading cause of human death and about 1 in 6 deaths is due to 
cancer and an estimated 9.6 million deaths in 2018 (WHO, 2018). Most of the cancer 
causing deaths (70%) occurs in middle and low income countries. In 2018, an 
estimated 18.1 million new cases and 9.6 million cancer deaths were reported. Lung 
cancer is listed as the highest diagnosed cancer (11.6%) and the prominent cause of 
death (18.4%), followed by female 11.6% of breast cancer, 7.1% of prostate cancer 
and 6.1% of colorectal cancer (Bray et al.,2018). Most of the cancer causing deaths is 
due to tobacco and alcohol use, low intake of vegetable and fruits, high body mass 
index and lack of physical activity. Worldwide, about 2.1 million newly diagnosed 
female breast cancer cases reported in 2018. This cancer types is the most commonly 
diagnosed cancer in the majority of the nations accounting for 1 in 4 cancer cases 
among women (Bray et al., 2018). Similarly, the cancer burden in United Arab 
Emirates was ranked the second foremost cause of non-communicable diseases related 
mortality in the country (WHO, 2014; Loney et al., 2013).  
Globally, UAE become one of the fastest growing economies (Shihab et al., 
2001) with this growth leading to economic, sociodemographic, and lifestyle changes, 
paralleled by an epidemiological increase in the rates of non-communicable diseases. 
Among women in Arab countries, Breast cancer is the most common (El Saghir et al., 






with an associated mortality rate of 12.4% were reported in 2018 (WHO, 2018). Breast 
cancer is associated with three immunohistochemical biomarkers such as progesterone 
receptor, human epidermal growth factor 2 and Estrogen Receptor (McAnena et al., 
2018). The four molecular subtypes [luminal A (ER/PR +ve, HER2 -ve), luminal B 
(ER and/or PR +ve, HER2 +ve), HER2 over-expressing (HER2 +ve alone) and triple 
negative (-ve for all 3 receptors)] of breast cancer are defined by the presence or 
absence of above mentioned receptors (Network, 2012). Each subtype shows separate 
rate of recurrence, prognoses and varied treatment strategies (Sørlie et al., 2001).  The 
primary treatment option for breast cancer is to remove the entire tumor. However, this 
treatment of is no longer possible if it spread to other parts of the body. Now a day, 
there are number of treatment options viz., chemotherapy, hormone therapy, targeted 
therapies and radiotherapy etc. In most cases, the treatments can be combined or 
various treatments are used one after other. Depends on response of tumors the 
treatment approach can be varied. However, these treatment options having some 
undesirable side effects such as hair loss, muscle and joint problems, lower bone 
density, sleep problems, damages healthy body cells, mouth sores, nausea and 
indigestion, dry skin and dry mucous membranes, anemia, susceptibility to infections, 
fatigue, nausea, vomiting, diarrhea, heart issues and tiredness etc. (IQWiG, 2006). 
Hence, the innovation and development of new anticancer molecules from nature have 
been focused (Wright, 2017; Yao et al., 2017).  
1.2 Plant based drugs 
Plants have long held a prominent place as a source of new drugs, accounts of 
their use dating as far back as 4000 BC (Nickell, 1959). The WHO states that about 
three-quarters of the world peoples trusts upon traditional therapies (mainly herbs) for 






not only provided shelter and food but also helped the humanity to treat many diseases. 
Most of plant derived drugs were discovered by the study of traditional and folk 
knowledge and some of these could not be replaced despite the enormous advancement 
in synthetic chemistry (Gilani and Rahman, 2005). Complex and varied natural 
products have yielded many active lead molecules for the discovery of new medicines.  
Naturally derived molecules have exhibited tremendous biological activities 
including anticancer activity (Huang et al., 2019).  As a key source of drugs, naturally 
derived molecules play a significant role in the discovery of new drugs. More than 
60% of antitumor medicines are closely associated to natural products. The anticancer 
activity of natural molecules often act by inducing autophagy or apoptosis, or 
inhibiting cell proliferation and regulating immune function (Rayan et al., 2017). 
Besides, in clinical treatment, the abnormal activity of tyrosine kinase has become an 
vital target since it is the main cause of tumors. However, natural products are guiding 
the discovery of new tyrosine kinase inhibitors with its molecular structure diversity 
and unique mode of action. Development of new anticancer drugs with tyrosine kinase 
inhibitory potential from natural source will bring new advances anticancer drugs 
development (Yin et al., 2019). Plant derived molecules such as alkaloids, terpenoids, 
flavonoids, saponins, polysaccharides and other molecules have been reported as 
natural bioactive molecules with potent anticancer activity (Avato et al., 2017; Joshi et 
al., 2017; Majumder et al., 2017). 
The United Arab Emirates has a rich tradition of herbal medicine and 
numerous traditional systems of medicine were used for the health care treatment. In 
addition to plant based medicines, other treatments such as cupping, bone settings 






are used as part of the treatment (Ghazanfar, 1994). The country is home to around 
731 vascular plant species and has the fourth largest number of angiosperm plants in 
Arabian Peninsula and about 260 plants are used for medicinal practices (Sakkir et 
al., 2012). 
1.3 Genus Moringa and its importance 
The genus Moringa is the sole representative of the family Moringaceae and 
the distribution of this extends across continents. The species also cultivated in 
different parts of world especially in Asia and Africa for variety of applications. The 
genus Moringa is utilized for its multiple uses. Historical evidence indicated that 
different civilizations viz., Egyptian, Indian and Greek were using Moringa for several 
purposes for thousands of years.  To maintain their mental fitness and skin health, they 
desired to have the fruits and the leaves of Moringa in their daily diet. Moreover, the 
juice gives added energy to the soldiers in the war field. The leaf extracts of Moringa 
were given to the ancient Maurian warriors as it was believed that the decoction 
discharges them from the stress and pain earned during the war (Jahn, 1986; Manzoor 
et al., 2007; Fuglie, 2001). The civilizations of ancient Egyptian, Greek and Roman 
were highly valued the Ben oil (Edible oil) from Moringa seeds for making perfume 
and protecting their skin. The Egyptians used the ben oil since the middle and old 
kingdoms (3000-2000 BC) (Miller and Morris, 1988; ICUN, 2005). Fahey (2005) 
reports that the seeds of this plant species are used in water purification, the leaves are 
source of very important nutrients, the oil is used as biofuel, the trunks produce gum, 
the flowers produce honey and all plant parts can be used for various medicinal 
purposes. The real potentials of Moringa species should be capitalized for the great 
benefit to the rural people in many parts of the world who depend mostly on 






these valuable species will properly be noticed and received the attention which the 
plants rightfully deserve (Padayachee and Baijnath, 2012). There are 13 species under 
this genus which includes M. arborea, M. borziana, M. concanensis, M. drouhardii, 
M. hildebrandtii, M. longituba, M. oleifera, M. ovalifolia, M. peregrine, M. pygmaea, 
M. rivae, M. ruspoliana and M. stenopetala (TFLI, 2014). Though there are enormous 
reports on different parts of few species from the genus Moringa, it is still the genus 
the species of which have not been explored completely.  The Moringa species have 
attained broad research interest because of their excellent economic potential (Arora et 
al., 2013). Among the different species under Moringa, current investigation is focused 
to Moringa peregrina. The other species are being studied and explored minimally for 
naturally occurring bioactive constituents (Rani et al., 2018).  
1.4 Relevant Literature 
Moringa peregrina and its pharmacological potential 
This plant originated in Arabian Peninsula (Bellostas et al., 2010) and well 
adapted to extreme climate conditions (Robiansyah et al., 2014).  This plant is a fastest 
growing tree (Abd El-Wahab, 1995) with the height of 3-10 m (Bellostas et al., 2010). 
M. peregrina is generally distributed in Saudi Arabia (Migahid, 1978) Baluchestan, 
Iran (Ghahreman, 2001), Yemen, Somalia, (Somali et al., 1984), Oman (Al-Owaisi et 
al., 2014) and in Jordan (Al-Dabbas et al., 2010). Around 5000 years ago, the healing 
potential of Moringa was documented in the Indian Vedic litrature (Patwardhan, 
2000).  The plant has many medicinal values both in folk and traditional medicine 
(Miller and Morris, 1988; Ghazanfar and Al-Al-Sabahi. 1993; Al-khatani, 1995; 
Reddy et al., 2015). In traditional and folk medicine, the young leaves are used as 
antioxidant and wound healing and the juice of bark is used as a disinfectant (Marwah 






slimness, constipation, labor pain and burns (Boulos, 2000; Elbatran et al., 2005; 
Tahany et al., 2010). The convulsions or infantile paralysis is treated by pod oil (Miller 
and Morris, 1988). In folk medicine, the leaf extract is rubbed over skin for the 
treatment of skin rashes and paralysis (Ghazanfar and Al-Al-Sabahi, 1993).  Seeds of 
M. peregrina are used very commonly to control diabetes (Al-Kahtani, 1995; Reddy et 
al., 2015). The seeds also used for the treatment of symptoms related to diabetes viz., 
hyperglycemia and hyperlipidemia.  Seeds of the plant are used for treatment of 
abdominal pain (Van der Vossen and Mkamilo, 2007). For wound healing purpose, the 
leaves are used (Nawash and Al- Horani, 2011). The roots and leaves of M. peregrina 
are used to treat stomach disorders, malaria, asthma, hypertension, to expel a retained 
placenta and diabetes (Mekonnen et al., 1999). Also, the oil of the plant is used to treat 
scabies, itches and freckles, (Al-Dhaheri, 2016). Scientifically, the M. peregrina plant 
parts such as leaves, roots and flowers were studied for many pharmacological 
activities such as anti-diabetic, anticancer, antimicrobial, hypertension, anti-
inflammatory, antioxidant, anti-spasmodic, hepatotoxicity, memory disorders and 
lipid lowering activity and also, the plant has yielded some active molecules. 
Recently, Senthilkumar et al. (2018) extensively reviewed traditional uses, biological 
activity and phytochemistry of M. peregrina.   
1.4.1 Anti-spasmodic 
Sadraei et al.  (2015) was studied anti-spasmodic effect of leaves and seeds M. 
peregrina by ileum contractions. Both the leaves and seed extracts had inhibitory 
effect on ileum contractions induced by acetylcholine, electrical field stimulation, and 
KCl. The seed extract had more potential with the IC50 values of 230 (electrical field 






showed inhibitory potential of ileum contraction with the IC50 values of 314 (electrical 
field stimulation), 365 (acetylcholine) and 439 (KCL) μg/ml.   
1.4.2 Anti-diabetic 
Different M. peregrina extracts were studied for its hypoglycemic properties. 
Hydroalcoholic extract of seeds of M. peregrina was studied for antidiabetic 
potential against streptozotocin induced diabetic rats (El-Haddad et al., 2002). The 
level of blood glucose was decreased by the fractions of chloroform and petroleum 
ether. Elbatran et al. (2005) investigated the antidiabetic potential of ethanolic extract 
of M. peregrina. The levels of aspartate aminotransferase, serum glucose and alanine 
aminotransferase were decreased significantly by the extract.  The authors also 
observed that the low density lipoprotein, cholesterol and serum triglycerides were 
decreased through the administration of M. peregrina extract. The ethanol and 
aqueous seed extracts of M. peregrina were investigated for their anti- diabetic 
activity (Koheil et al., 2013). The level of blood glucose was reduced when the rats 
treated with a dose of 150 mg/kg body weight. The administration of M. peregrina 
aqueous ethanolic extracts reduces the values of reduced glutathione and nitric oxide 
values close to the normal level. The authors also observed the low levels of 
enzymatic antioxidants such as superoxide dismutase, catalase and glutathione 
peroxidase. Hydro-alcoholic extract of M. peregrina dried leaves inhibited the 
enzymes viz. dipeptidyl peptidase IV, α-amylase and α-glucosidase and (Ullah et al., 
2015). The pancreatic α-amylase inhibitory potential of M. peregrina showed that the 
enzyme responded to the extract depended on concentration. Also, in a dose dependent 






1.4.3 Anti-inflammatory  
Previously, ethanol and aqueous extracts from M. peregrina were 
investigated for anti-inflammatory (Koheil et al., 2011). The study was conducted 
using inflammation in rats induced by fresh egg albumin. Both the extracts were 
reduced the acute inflammation significantly. 72.96 and 81.01% of inflammation were 
reduced by the aqueous and ethanol extracts respectively at a dose of 300 mg/kg. 
Whereas, the control drug reduced 100% of the inflammation at the dose of 100 
mg/kg.  
1.4.4 Antioxidant 
 The antioxidant effect of aqueous and ethanol extracts M. peregrina was 
studied by Marwah et al. (2007). Both the extracts showed good antioxidant effect 
with the IC50 value of 7.6 µg/ml. Aqueous and ethanol extracts of seeds of M. 
peregrina were investigated for antioxidant activity Koheil et al. (2011).  Both the 
extracts were studied for different antioxidant potentials viz., DPPH free radical 
scavenging ability, superoxide anion scavenging activity, chelating effect of ferrous 
ions, hydroxyl radical scavenging potential, reducing power and hydrogen peroxide 
scavenging potential and the results were compared with the control. The highest 
antioxidant activity was recorded in ethanol extract at 6 mg/ml concentration. At the 
same concentration, free radical scavenging potential of the aqueous extract was nearly 
equal to trolox. Further, the results on superoxide anion scavenging potential indicated 
that both the extracts displayed worthy superoxide anion scavenging activity than 
BHA. The results on chelating potential indicated that the activity dose depended 
manner and the inhibition were 60% and 37% for ethanol and aqueous extracts 






ethanol was closely equal to the standard, EDTA. The hydroxyl radical scavenging 
activity was same at 20 and 40 µg/ml concentration for both the extracts. However, the 
ethanol extract exhibited hydroxyl radical scavenging activity than the control, 
ascorbic acid. At a concentration of 100 μg/ml, 65% and 79% of hydrogen peroxide 
radicals were scavenged by aqueous and ethanol extracts respectively. While, the 
control BHT, BHA and α-tocopherol scavenged 28, 35 and 75% respectively.  Both 
the extracts exposed similar reducing power potential comparable to that of control, α-
tocopherol. 
Dehshahri et al. (2012) studied the antioxidant activity of different extracts of 
leaves of M. peregrina. All the extracts showed significant H2O2 activity. The M. 
peregrina extracts showed good DPPH free radical scavenging activity with the EC50 
values of 4.4 μg/mL (Moustafa et al., 2014). Ullah et al. (2015) studied the ABTS•+ 
radical scavenging activity of M. peregrina hydro-alcoholic extract and the extract 
showed dose dependent activity with an IC50 value of 20.56 μg/mL. El-Awady et al. 
(2016) reported the antioxidant activity of methanol and aqueous extracts of M. 
peregrina. The highest DPPH scavenging potential (165.49 mg ascorbic acid 
equivalent) was observed in methanol extract. The seed oil of M. peregrina showed 
good DPPH scavenging activity at 172 mMol Trolox equivalent/kg (Elabd et al., 
2017). Young M. peregrina leaf extract exhibited DPPH free radical inhibition of 
74.78% (Juhaimi et al., 2017). 
1.4.5 Antimicrobial 
 Previously, M. peregrina were investigated for its antibacterial, antiviral and 
antifungal potential. The ethanol extract of M. peregrina were investigated for anti-






peregrina hydro-alcoholic extract showed the antiviral activity against herpes 
simplex-1 virus (Soltan and Zaki, 2009). However, the extract was found to be 
inactive against vesicular stomatitis and poliomyelitis-1 viruses.  
M. peregrina seed oil was studied for antimicrobial activity against 
Escherichia coli, Enterobacter cloacae, Staphylococcus epidermidis, Pseudomonas 
aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, Candida glabrata, C. 
albicans and C. tropicalis (Lalas et al., 2012). The authors compared the activity 
with the standard antibiotics. The oil showed good anti-microbial activity against all 
the microorganisms and C. glabrata was detected as a most resistant strain to the 
extract. Ethanol extract of M. peregrina leaves, seed coat and endosperm was studied 
for antimicrobial activity against various strains of bacteria and fungus (Hajar and 
Gumgumjee, 2014). The M. peregrina leaf extract displayed notable antibacterial 
activity. The antibacterial activity of ethanol and methanol leaf extracts of M. 
oleifera and M. peregrina was compared. Both the plant extracts showed good 
antibacterial potential against Aeromonas hydrophila, P. aeruginosa, Enterococcus 
sps, E. coli and S. aureus. However, M. peregrina has less activity compared to M. 
oleifera (El-Awady et al., 2015). Majali et al. (2015) studied the ethanol extract of M. 
peregrina seeds, leaves and roots for antibacterial activity against Klebsiella 
pneumonia, E. coli and S. aureus. Among the samples, the root extract had good 
antibacterial potential with the zone of inhibition of 44‒59 mm (K. pneumonia), 18‒ 
42 mm (E. coli) and 34‒ 45 mm (S. aureus). The activity was in order of root extract 
followed by leaf ethanol extract and seed extract. 
Different bacterial strains Viz. E. coli ATCC 29522 and O157:H7, S. aureus, 






Salmonella paratyphi, Enterobacter aerogenes, Salmonella typhimurium and 
Pseudomonas aeruginosa were used to study the antibacterial ability of acetone, 
ethanol, methanol and aqueous extracts of both field grown samples and in vitro 
plantlets of M. peregrina (Alrayes et al., 2016). The results indicated that the in vitro 
plantlets displayed good antibacterial activity. The seed aqueous extract of M. 
peregrina was screened for antibacterial activity against multidrug resistant 
Salmonella species. The extract showed good activity with a minimum inhibitory 
concentration ranged between 109.37 and 437.5 mg/mL (Saleh et al., 2017). 
1.4.6 Hypertension 
The M. peregrina hydroalcoholic extract was investigated on oxidative status 
and blood pressure in hypertensive rats induced with dexamethasone. body weight, 
thymus weight, antioxidant power, concentration of plasma hydrogen peroxide and 
systolic blood pressure were measured to find out the effect (Safaeian et al., 2015). 
The authors reported that 400 mg/kg dose level of M. peregrina extract prevents the 
rise of blood pressure. While, the reversal study showed that the extract failed to lower 
the SBP in in rats. It has no effect on the thymus weight loss and failed to prevent the 
changes in body weight. But, the other report revealed the M. peregrina seed extract 
decreased the weight of the body and the administration of 200 and 400 mg/kg dose 
prevented the rise of concentration of  H2O2 (Rouhi-Broujeni et al., 2013). The reduced 
antioxidant power was observed in the rats administrated with 400 mg/kg of M. 
peregrina extract (Safaeian et al., 2015). So, the availability of antioxidant molecules 







Seed oil M. peregrina with the dose of 150 mg/kg reduced the damage of 
mice liver in doxorubicin induced liver damage (Sliai and Abdel-Rahman, 2016). 
The results indicated that the reduction in apoptotic index and caspase-3 
immunoreactivity of mice treated with seed oil of M. peregrina. The oil also 
investigated along with other species of Moringa for oxidative stress state of liver 
tissue in liver damage treated with high fat diet (Elabd et al., 2017). The authors 
analysed the marker enzymes such as total serum cholesterol, glucose, lipid 
peroxidation, high-density lipoprotein cholesterol, low-density lipoprotein 
cholesterol, triacylglycerol and antioxidant enzymes after the treatment. The results 
showed the increased total serum cholesterol, alanine transaminase, glucose, 
aspartate transaminase and body weight in high fat diet fed rats. The seed oil also 
improved the content of glucose, liver enzymes and lipid profile significantly.  M. 
peregrina ethanol leaf extract reduced the activities of serum hepatic marker 
enzymes (Azim et al., 2017). The authors noted that the antioxidant enzymes were 
reduced in acetaminophen intoxicated rats. Whereas, the enhanced activities of 
glutathione peroxidase, superoxide dismutase and catalase were noted in the rats 
administrated with the leaf extract of M. peregrina.  
1.4.8 Anti-cancer 
In earlier studies, seed oil of M. peregrina was reported for anticancer 
activity on different cell lines viz. colon cancer, liver cancer, mouse fibroblasts, 
cervical cancer and breast cancer cell lines (Elsayed et al., 2016). The results 
revealed that the oil showed significant anticancer activity against all the cell lines 






colon cancer, liver cancer, mouse fibroblasts, cervical cancer and breast cancer cell 
lines respectively. 
However, the root tubers of M. peregrina were not studied before, as 
formation of root tubers is the unique feature of M. peregrina during the seedling 
phase (Munyanziza and Yongabi, 2007). Therefore, the preset work was aimed to 
study the phytochemical analysis and anticancer activity of M. peregrina tuber 
extracts with the following objectives. 
• To collect the root tubers of M. peregrina  
• To prepare the crude extracts from the root tubers using different organic 
solvents viz., hexane, chloroform, acetone and methanol.  
• To analyze the phytochemical compositions of the crude extracts by GC-MS. 








Chapter 2: Materials and Methods 
 
2.1 Plant materials 
The root tubers of Moringa peregrina were collected from six months older 
plants from Al Foah Experimental Farm [24°21’31.139’’N 55°47’57.239” E (Altitude 
303 M)], Al Ain, UAE. The collected samples were again washed then the root tubers 
were made into small pieces using cutter and shade dried in the laboratory. The dried 
samples were again dried in hot air oven (50ºC) and powdered in a grinding mill. The 
powdered plant samples were stored in airtight containers for the preparation of crude 
extracts (Figure 1). 
    
  






2.2 Preparation of crude extracts 
The crude extracts were prepared using a Soxhlet apparatus with increasing 
polarities of organic solvents viz., hexane, chloroform, acetone and methanol. The extracts 
were combined, dried stored at +4°C for GC-MS analysis and anticancer activity.  
2.3 Gas chromatogram and GC- Mass Spectrometry analysis  
 GC (Gas chromatogram) was done using Gas Chromatography (Agilent 
Technologies) which was equipped with automatic liquid sampler and mass selective 
detector. The chromatograph was built-in with HP 5 MS capillary column (30 m×250 
µm i.d., film thickness 0.25 µm). The injector temperature was kept at 250ºC and the 
oven temperature was begin with 70ºC and programmed to 450ºC (10ºC/min) and 
finished 300ºC for 9 mts. The plant sample was diluted with acetone (1:10) and one 
microlitre of sample was in the split mode in the rate of 1:100. Helium was used as 
carrier gas and the flow rate was 1.5 ml/min. The % of each chemical compound of 
the plant extract was calculated by GC peaks areas without any correction factors. 
GC-mass spectrometry (GC-MS) was achieved using the same chromatography fitted 
with mass spectrometer. Same GC conditions were adopted and the same column 
(HP 5 MS) was used. Ion source and transfer line temperature was kept at 240ºC and 
mass spectra were obtained by centroid scan of the mass range between 40 and 700 
amu. Retention time (RT), retention indices (RI), mass spectra of NIST and WILEY 
library data of the GC-MS were compared to identify each chemical compound. 
2.4 Anti-cancer activity of crude extracts  
2.4.1 Cell culture and cell viability Assay 
Human breast cancer cell line (MCF-7) was purchased from European 






essential medium supplemented with 10% heat-inactivated fetal bovine serum and 
1% penicillin-streptomycin.  The cultures were maintained at 37°C in a humidified 
atmosphere with 5% CO2 in the incubator. After the cells grown in the 75mm flask, 
trypsinised and transferred into the new flask. Continue the process for couple of 
passages until the cells become healthy. Cells were collected from the 70% confluent 
flask, placed in 96-well culture plates at a density of 2 × 104 cells/well and incubated 
at 37°C for 24 h. After incubation, cells were treated with different concentrations of 
the extracts viz. 10, 20, 40, 80, 160 and 380 µg/ml. The stock solution of extracts was 
prepared in dimethyl sulfoxide (DMSO) and stored at −20°C until use. These cells 
were further incubated for 72 h, after which the cell viability was measured using the 
WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1, 3-benzene 
disulfonate) (Abcam, Cambridge, USA) colorimetric assay. After the addition of 
10ul of wst-1 reagent into each well, cells were incubated at 37oC for 4 hours. Each 
96 well plate was kept in a Shaker for one minute with gentle shaking and the plate 
were measured the absorbance of color changes at 450 nm wavelength in the 
microplate reader (Thermo Scientific Multiscan GO, Waltham, MA USA). 
Doxorubicin was used as a standard. The growth inhibition percentage was 
calculated using the formula Inhibition % = (OD of Control – OD of sample)/OD of 
Control) x 100. The IC50 values were calculated through dose-response curves for 
each cell line. 
2.5 Statistical evaluation 
IC50 values for anticancer tests were derived from a nonlinear regression 
analysis (curve fit) based on sigmoid dose response curve (variable) and computed 
using Graph Pad Prism 6 (Graph pad, SanDiego, CA, USA). Calculated the standard 






Chapter 3: Results 
 
In the present study, the chemical composition and anticancer activity of 
hexane, chloroform, acetone and methanol extracts of root tubers of M. peregrina 
were studied. The chemical composition of four different extracts was analyzed by 
Gas Chromatography, Mass Spectrometry and the gas chromatograph of each 
extracts are given in Figures 2-5, and list of chemical compounds are presented in 
Table Nos. 1-4. Anticancer activity of the extracts was performed on human breast 
cancer cell line (MCF-7) and the results are presented in Figures 6-9 and Table 5.  
3.1 Chemical composition of different solvent extracts of M. peregrina root 
tubers 
The results on chemical composition of hexane extract of M. peregrina root 
tubers are presented in Table 1 and gas chromatogram is given in Figure 2. A total of 
33 compounds were identified and the major compounds was β-Sitosterol (16.90%) 
followed by Stigmasterol (12.36%), 24-methyl- 5-Cholestene-3-ol (11.83%), cis-10-
Heptadecenoic acid (10.85%), n-Hexadecanoic acid (8.95%), cis-Vaccenic acid 
(8.5%), Methyl cis, cis-9,12-octadecadienoate (5.20%), 8-Octadecenoic acid methyl 
ester (5.09%), 4-methyl-methyl ester Pentadecanoic acid (4.66%), (3β)- 9,19-
Cyclolanostan-3-ol, 24-methylene (1.91%), Oleic Acid (1.70%) and 9-Octadecenoic 
acid (Z) Methyl ester (1.46%). Other compounds such as Methyl stearate (0.96%), 4-
methoxy- 1H-Benzotriazole (0.93%), (Z,Z)- 9,12-Octadecadienoyl chloride (0.86%), 
(E)- 9-Octadecen-1-ol  (0.84%), Docosanoic acid methyl ester (0.78%), Methyl 18-
methylnonadecanoate (0.73%), 9-Phenyl-5H-benzocycloheptene (0.70%), 1H-S-
























(RT) Name of the Compounds Percentage 
1 16.467 Cyclotetradecane 0.23 
2 16.681 methyl ester (Z)9-Hexadecenoic acid  0.29 
3 16.913 4-methyl-methyl ester Pentadecanoic acid 4.66 
4 17.074 cis-9-Hexadecenoic acid  0.48 
5 17.395 n-Hexadecanoic acid 8.95 
6 17.561 Octadecanoic acid 0.13 
7 17.871 15-methyl-, methyl ester Hexadecanoic acid 0.52 
8 18.210 (E)- 9-Octadecen-1-ol 0.84 
9 18.513 Methyl cis,cis-9,12-octadecadienoate 5.20 
10 18.578 8-Octadecenoic acid methyl ester 5.09 
11 18.626 9-Octadecenoic acid (Z) Methyl ester 1.46 
12 18.804 Methyl stearate 0.96 
13 19.030 cis-10-Heptadecenoic acid 10.85 
14 19.084 cis-Vaccenic acid 8.50 
15 19.220 Oleic Acid 1.70 
16 19.363 Estra-1,3,5(10)-trien-17β-ol 0.35 
17 19.423 (Z)- 9,17-Octadecadienal 0.22 
18 20.326 4-methyl- Cyclopentadecanone 0.30 
19 20.552 Methyl 18-methylnonadecanoate 0.73 
20 20.980 Eicosanoic acid methyl ester 0.13 
21 22.164 Docosanoic acid methyl ester 0.78 
22 23.400 (Z,Z)- 9,12-Octadecadienoyl chloride 0.86 
23 23.662 Tetracosanoic acid methyl ester 0.43 
24 24.578 1H-S-Triazolo[1,5-a]pyridin-4-ium, 2-hydroxy-
1-methyl-, hydroxide 
0.69 
25 25.803 4-methoxy- 1H-Benzotriazole 0.93 
26 26.207 1-Heptacosanol 0.23 
27 26.302 Arsenous acid, tris(trimethylsilyl) ester 0.22 
28 27.146 24-methyl- 5-Cholestene-3-ol 11.83 
29 27.360 Stigmasterol 12.36 
30 27.919 β-Sitosterol 16.90 
31 27.979 α-Amyrin 0.57 
32 28.246 9-Phenyl-5H-benzocycloheptene 0.70 
33 29.198 (3β)- 9,19-Cyclolanostan-3-ol, 24-methylene 1.91 







 (0.57%), 15-methyl-, methyl ester Hexadecanoic acid (0.52%), cis-9-Hexadecenoic acid 
(0.48%), Tetracosanoic acid methyl ester (0.43%), Estra-1,3,5(10)-trien-17β-ol (0.35%), 
4-methyl- Cyclopentadecanone (0.30%), methyl ester (Z)9-Hexadecenoic acid (0.29%), 
Cyclotetradecane (0.23%), 1-Heptacosanol (0.23%), (Z)- 9,17-Octadecadienal (0.22%), 
Arsenous acid, tris(trimethylsilyl) ester (0.22%), Octadecanoic acid (0.13%) and 
Eicosanoic acid methyl ester (0.13%) were identified as minor compounds.   
The GC-MS analyses revealed that the chloroform extract of M. peregrina tubers 
contains fifty compounds and the results are presented in Figure 3 and Table 2. In 
chloroform extract, Hexylene glycol (36.35%) and 4,5-Diaminobenzofurazan (12.59%) 
were identified as the major compounds. 5.81% of N-(phenylmethyl)- Acetamide, 5.5% 
of 3-methyl- Butanamide, 5.13% of Tetradecanoic acid, 3.72% of N-Benzylformamide,  
3.18% of 9-Hexacosene, 2.38% of 1-(phenylmethyl)- 3-Pyrrolidinone and 2.27% of (Z)-
13-Octadecenal were also identified as prominent chemical compounds. Whereas, 4,5-
dimethyl-2-phenyl- 1,3-Dioxolane (1.82%), (Z)-9,17-Octadecadienal (1.64%), 2-
hydroxy-1-methylpropyl esterStearic acid (1.55%), 1-phenyl- 1,2-Ethanediol (1.42%), 
2,2,2-trifluoro-N-(phenylmethyl)- Acetamide (1.37%), N-Benzylbenzamide (1.26%), Z-
7-Hexadecenoic acid (0.98%), β-oxo-4-phenyl-1-Piperazinepropanenitrile (0.95%), α-
Methylbenzylamine (0.88%),  Benzyl alcohol (0.81%), Hexadecanoic acid ethyl ester 
(0.80%), (isothiocyanatomethyl)- Benzene (0.79%), Isopropyl palmitate (0.65%), 7-
ethyl-2-methyl-4-Undecanone (0.59%), 2-Methoxydiftalone (0.54%), α- [N-
Nitrosoanilino] thioacet amide (0.52%), 1-methyl-5,7-Indolinedicarboxaldehyde 
(0.43%), 1,1,2,3,3-pentachloro- Propane (0.37%), Methyl 10-trans, 12-cis-


































Name of the Compounds Percentage 
1 5.360 Benzyl alcohol 0.81 
2 6.984 1,1,2,3,3-pentachloro- Propane 0.37 
3 6.984 Methyl 10-trans, 12-cis-octadecadienoate 0.37 
4 8.167 Hexylene glycol 36.35 
5 8.434 3-methyl- Butanamide 5.50 
6 8.827 1-(phenylmethyl)- 3-Pyrrolidinone 2.38 
7 9.380 1-benzyl-2,2,3,3-tetram Azetidine 0.37 
8 9.528 4,5-dimethyl-2-phenyl- 1,3-Dioxolane 1.82 
9 10.016 N-(1,1-dimethylethyl)- Benzamide 0.12 
10 10.093 1-phenyl- 1,2-Ethanediol 1.42 
11 10.498 (isothiocyanatomethyl)- Benzene 0.79 
12 10.973 N-Benzylformamide 3.72 
13 11.348 4-hydroxy- Benzeneethanol 0.30 
14 11.449 N-(phenylmethyl)- Acetamide 5.81 
15 11.788 Tetradecamethy l- Cycloheptasiloxane 0.27 
16 12.044 4,5-Diaminobenzofurazan 12.59 
17 12.317 2,4-bis(1,1-dimethylethyl) Phenol 0.30 
18 12.442 N-Carbamoylmethyl-N-phenylacetamid 0.20 
19 12.930 1,4-dihydro-1-methyl-4-oxo-3-Pyridinecarbonitrile 0.15 
20 13.726 N-methyl-β,3, 4-tris(trimethylsiloxy)- Phenethylamine 0.12 
21 14.172 2,2,2-trifluoro-N-(phenylmethyl)- Acetamide 1.37 
22 14.529 1-methyl-5,7-Indolinedicarboxaldehyde 0.43 
23 14.755 N-(phenylmethyl)- 1,2-Ethanediamine 0.14 
24 15.046 1-Benzylamino-6-benzyloxyhexane 0.19 
25 15.124 N-hydroxy-N-(p henylmethyl)-Benzenemethanamine 0.14 
26 15.278 1-(4-butylpheny)- Pyrrole-2,5-dione 0.12 
27 15.718 7-ethyl-2-methyl-4-Undecanone 0.59 
28 16.325 β-oxo-4-phenyl-1-Piperazinepropanenitrile 0.95 
29 16.896 14-methyl-Pentadecanoic acid methyl ester 0.29 
30 17.068 Palmitoleic acid 0.23 
31 17.282 Tetradecanoic acid 5.13 
32 17.496 2-(1,1-dimethylethyl)-6-methyl-1,3-Dioxan-4-one 0.31 
33 17.561 Hexadecanoic acid ethyl ester 0.80 
34 17.621 α-[N-Nitrosoanilino]thioacet amide 0.52 
35 17.841 Isopropyl palmitate 0.65 
36 17.972 N-Benzylbenzamide 1.26 
37 18.245 N,N'-Nonamethylenebis[-S-3-aminopropyl thiosulfuric 
acid] 
0.36 
38 18.870 Z-7-Hexadecenoic acid 0.98 
39 18.923 9-Hexacosene 3.18 
40 19.161 (Z)-13-Octadecenal 2.27 
41 19.357 cis-11,14-Eicosadienoic acid methyl ester 0.26 
42 19.411 2-Methyl-Z,Z-3,13-octadecadienol 0.30 
43 19.476 Benzylammoniotris(trifluoromethyl) borinate 0.36 
44 20.332 2-hydroxy-1-methylpropyl esterStearic acid 1.55 
45 20.963 α-Methylbenzylamine 0.88 
46 21.105 2-Methoxydiftalone 0.54 
47 21.730 (Z)-9,17-Octadecadienal 1.64 
48 22.729 5-[4-Methoxyphenoxy]-6-amino-8-methoxyquinaldine 0.28 
49 23.192 2,2'-dithiobis[5-nitro-Pyridine 0.34 
50 25.969 Tris(tert-butyldimethylsilyloxy)arsane 0.18 







Azetidine (0.37%), N,N'-Nonamethylenebis[-S-3-aminopropyl thiosulfuric acid] 
(0.36%), Benzylammoniotris(trifluoromethyl) borinate (0.36%), 2'-dithiobis[5-nitro-
Pyridine (0.34%), 2-(1,1-dimethylethyl)-6-methyl-1,3-Dioxan-4-one (0.31%), 4-
hydroxy- Benzeneethanol (0.3%), 2,4-bis(1,1-dimethylethyl) Phenol (0.3%), 2-
Methyl-Z,Z-3,13-octadecadienol (0.3%), 14-methyl-Pentadecanoic acid methyl ester 
(0.29%), 5-[4-Methoxyphenoxy]-6-amino-8-methoxyquinaldine (0.28%), 
Tetradecamethy l- Cycloheptasiloxane (0.27%), cis-11,14-Eicosadienoic acid methyl 
ester (0.26%), Palmitoleic acid (0.23%), N-Carbamoylmethyl-N-phenylacetamid (0.2%), 
1-Benzylamino-6-benzyloxyhexane (0.19%), Tris(tert-butyldimethylsilyloxy)arsane 
(0.18%), 1,4-dihydro-1-methyl-4-oxo-3-Pyridinecarbonitrile (0.15%), N-(pheny- -
lmethyl)- 1,2-Ethanediamine (0.14%), N-hydroxy-N-(p henylmethyl)-Benzene- -
methanamine (0.14%), N-(1,1-dimethylethyl)- Benzamide (0.12%), N-methyl-b,3, 4-
tris(trimethylsiloxy)- Phenethylamine (0.12%) and 1-(4-butylpheny)- Pyrrole-2,5-dione 
(0.12%) were identified as the minor compounds in chloroform extract of M. peregrina  
root tubers. 
 The gas chromatogram of acetone extract of M. peregrina root tubers 
is given in Figure 4 and the chemical compounds are listed in Table 3. As shown in 
table, GC-MS analysis of the extract resulted in the identification of ten compounds 
representing 100% of the extract. The major compounds were 3-methyl-3-butenyl)- 
Benzene (24.95%), 1-Benzylazetidine (18.24%), cis-13-Octadecenoic acid (15.89%), 
followed by 1-benzyltetrahydroisoquinoline (11.04%),  2,4,6-Cycloheptatrien -1-one, 
3,5-b is-trimethylsilyl (6.52%), 1-methyl- 4-Piperidinemethanol (5.86%),  E,Z-2,13-
Octadecadien-1-ol (5.56%),  1,1,1,3,5,5,5-Heptamethyltrisiloxane (4.67%), E-10-

































Name of the Compounds Percentage 
1 7.150 Benzyl nitrile  18.24 
2 8.755 3-methyl-3-butenyl)- Benzene 24.95 
3 12.317 1-Benzylazetidine 3.25 
4 17.252 E,Z-2,13-Octadecadien-1-ol 5.56 
5 18.204 E-10-Pentadecenol 4.02 
6 18.911 cis-13-Octadecenoic acid 15.89 
7 21.736 1-methyl- 4-Piperidinemethanol 5.86 
8 27.295 1,1,1,3,5,5,5-Heptamethyltrisiloxane 4.67 
9 27.818 1-benzyltetrahydroisoquinoline 11.04 
10 31.035 2,4,6-Cycloheptatrien-1-one, 3,5-b is-
trimethylsilyl 
6.52 
  Total  100 
 
The results on the chemical composition analysis of methanol extract of M. 
peregrina root tubers are given in Figure 5 and Table 4. Totally, 24 compounds were 
identified and 4-hydroxy- Benzeneacetonitrile was identified as a major compound 
among the compounds representing about 12.09% of the total extract. Moreover, l-
Valine, N-benzyloxycarbonyl-decyl ester (9.96%), Phenyl cyanide (9.8%), Benzoic 
acid (9.13%), 2-Benzyloxyethyl chloroformate (7.03%), Benzeneacetamide (6.55%), 
2,4-dihydroxy-Benzaldehyde (6.48%), 4-Benzylamino-1-methylcytosine (5.86%), cis-
13-Octadecenoic acid (4.77%), Benzeneacetic acid (4.56%), 2,2,6,6-tetramethyl-4-
Piperidinone (4.39%), 2,4-Dimethyl-2,4-pentanediol (2.82%), N-(phenylmethylene)- 
Benzenemethanamine (2.55%), (E)-2-Butenoic acid, 2-methylpropyl ester (2.47%), 
Benzyl isopropenyl ether (1.72%), 5-Hydroxymethylfurfural (1.39%), 1-(phenyl-
methyl)- dl-Proline (1.2%), Benzenemethanethiol (1.17%), (Z,Z)-9,12-Octadecadienoic 
acid (1.16%), 3-Amino-4-methylbenzamide  (1.12%), 2-Hydroxyethyl methacrylate 
(1.08%), Z-11-  Hexadecenoic acid (1.01%), 4-[(phenylmethyl)amino]-Phenol (0.93%) 
and Cyclopentadecane (0.76%) were also identified in methanol extract of M. peregrina 






3.2 Anticancer activity of different solvent extracts of M. peregrina root tubers 
Anticancer potential of various solvent extracts of M. peregrina root tubers on 
human breast cancer cell line (MCF-7) are presented in Table 5 and Figures 6 & 7. 
The activity was compared with the standard drug Doxorubicin and results revealed 
that all the four extracts were inhibited the breast cancer cells at the maximum 
concentration of 320 µg/ml. The highest activity was noted in chloroform extract 
with the inhibition percentage of 37.28, 48.53, 63.45, 72.14, 87.02 and 93.76 for 10,  
 
 











Name of the Compounds Percentage 
1 6.770  2,2,6,6-tetramethyl-4-Piperidinone 4.39 
2 7.126  Phenyl cyanide 9.80 
3 7.834  Benzoic acid 9.13 
4 8.256  2,4-Dimethyl-2,4-pentanediol 2.82 
5 8.518  5-Hydroxymethylfurfural 1.39 
6 8.797  Benzyl isopropenyl ether 1.72 
7 8.910  Benzeneacetic acid 4.56 
8 10.474  1-(phenylmethyl)- dl-Proline 1.20 
9 10.896  Benzeneacetamide 6.55 
10 11.092  3-Amino-4-methylbenzamide 1.12 
11 11.437  (E)-2-Butenoic acid, 2-methylpropyl 
ester 
2.47 
12 11.972  4-hydroxy- Benzeneacetonitrile 12.09 
13 14.624  4-[(phenylmethyl)amino]-Phenol 0.93 
14 15.118  N-(phenylmethylene)- 
Benzenemethanamine 
2.55 
15 15.677  2-Hydroxyethyl methacrylate 1.08 
16 17.068  Z-11-  Hexadecenoic acid 1.01 
17 17.163  Benzenemethanethiol 1.17 
18 17.276  2-Benzyloxyethyl chloroformate 7.03 
19 17.395  4-Benzylamino-1-methylcytosine 5.86 
20 18.073  Cyclopentadecane 0.76 
21 18.870  (Z,Z)-9,12-Octadecadienoic acid 1.16 
22 18.929  cis-13-Octadecenoic acid 4.77 
23 21.795  l-Valine, N-benzyloxycarbonyl-decyl 
ester 
9.96 
24 24.881  2,4-dihydroxy-Benzaldehyde 6.48 























Table 5: Anticancer activity of various solvent extracts of M. peregrina root tubers 













Hexane Extract 10 6.78 ±0.07  
315.0 
 20 11.92±0.83 
 40 17.46±0.84 
 80 25.03±0.97 
 160 33.11±0.89 
 320 51.03±0.53 
Chloroform Extract  10 15.1±0.22 
127.38 
 20 23.15±1.39 
 40 30.51±1.64 
 80 41.89±3.11 
 160 60.14±3.96 
 320 85.01±2.01 
Acetone Extract 10 5.93±0.08 
284.5 
 20 9.44±1.18 
 40 19.04±1.96 
 80 23.55±1.55 
 160 39.83±2.07 
 320 56.93±3.18 
Methanol Extract 10 3.54±0.27 
353.10 
 20 10.63±0.08 
 40 15.09±0.81 
 80 22.05±1.96 
 160 27.56±1.04 
 320 38.45±0.75 
    
Doxorubicin 3.125 9.453±0.15 
25.88 
 6.25 21.934±1.46 
 12.5 38.675±0.88 
 25 49.734±1.47 
 50 63.352±1.95 
 100 85.056±2.56 








Figure 6: Cell viability of human breast cancer cell line (MCF-7) treated with various 
extracts of M. peregrina root tubers and standard drug. ‘a-b’- Hexane extract; ‘c-d’ – 
Chloroform extract; ‘e-f’- Acetone extract; ‘g-h’-Methanol extract; ‘i-j’- Standard 
















Figure 7: Graphical representation of cell viability of human breast cancer cell line 
(MCF-7) with various extracts of M. peregrina root tubers and doxorubicin. A 
Hexane extract; B – Chloroform extract; C- Acetone extract; D-Methanol extract; E- 
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Figure 7: Graphical representation of cell viability of human breast cancer cell line 
(MCF-7) with various extracts of M. peregrina root tubers and doxorubicin. A 
Hexane extract; B – Chloroform extract; C- Acetone extract; D-Methanol extract; E- 
Standard drug, Doxorubicin (cont’d). 
20, 40, 80, 160 and 320 µg/ml concentrations respectively. The IC50 values for 
chloroform extract of root tubers was 127.38 µg/ml. While, the acetone extract 
showed moderate activity with the IC50 values of 284.5 µg/ml with the inhibition 
percentage of 5.93, 9.44, 19.04, 23.55, 39.83 and 56.93 for the tested concentrations. 
The hexane and methanol extracts of M. peregrina showed moderate activity against 
the cell lines tested. The hexane extract showed 51.03% of cell inhibition at the 
maximum concentration of 320 µg/ml. The methanol extract showed less activity 
when compared to other extracts texted with the inhibition percentage of 38.45 at the 
maximum concentration tested. The IC50 values of hexane and methanol extracts M. 
peregrina root tubers were 315.0 and 353.10 µg/ml respectively. Whereas, the 
standard Doxorubicin inhibited 85.056% of cells at the maximum concentration of 
100 µg/ml and the IC50 value was 25.88 µg/ml. There was no inhibition observed 
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Chapter 4: Discussion 
 
Phytochemicals from plants have become key sources in discovery and 
development of new drugs. For the last few decades, natural molecules especially the 
one having anticancer potential gained great attention. It has been studied for 
potential anticancer activity and low toxicity in normal cells (Newman and Cragg, 
2016; Tesfaye and Ravichadran, 2018). The pharmacological activity of plants 
extracts is mainly resulted from the mixture of compounds. Hence, it is essential to 
quantify the preliminary phytochemical composition to relate the biological potential 
and it will help to investigate the presence of particular class of phytochemicals. To 
best of my knowledge, there was no previous study on phytochemical analysis and 
pharmacological potential of root tubers of M. peregrina. However, the leaves of M. 
peregrina were reported for preliminary phytochemical screening. The hydro 
alcoholic extract of M. peregrina leaves were screened for phytochemical compound 
analysis (Ullah et al., 2015). The results showed the presence of different 
concentrations of phenolics, tannins, alkaloids, and saponins. These phytochemicals 
are plays vital role in biological activities (Ramawat et al., 2009). In the present study, 
β-Sitosterol was identified as the major compound (16.90%) in hexane extract of M. 
peregrina root tubers. β-Sitosterol is one of subcomponents of a group phytosterols 
found in all plants (Rakel, 2018). Stigmasterol also found as a major compound in the 
hexane extract (12.36%). The presence of these two compounds was already identified 
in the leaf methanol extract of Pongamia pinnata by GC-MS (Sangwan, 2019). β-
sitosterol also deducted in whole plant extracts of Leptadenia reticulata and Pluchea 
lanceolata (Mallick and Dighe, 2014). The authors High Performance Thin Layer 






50 compounds were identified in chloroform extract of M. peregrina root 
tubers. When compared to other extracts, the numbers of compounds were high in 
this extract. It is based on the solubility of phytochemicals in solvent as well as the 
elusion in GC column. Hexylene glycol was identified as the major compound 
(36.35%) by GC-MS. 4,5-Diaminobenzofurazan also occupied 12.59% of total 
extract. Al-Owaisi et al. (2014) reported the phytochemical composition of various 
solvent extracts viz. (hexane, chloroform, ethyl acetate and methanol) of leaves of M. 
peregrina. The authors identified a total of 32 compounds and 1-cyclohexyl ethanone 
occupied 27.26% followed by 17.11% of pentacosane, 16.57% of hexacosane, 
15.45% of tetracosane, 13.02% of heptacosane, 11.79% of tricosane, 9.10% of 
octacosane, 8.08% of cyclopentanol and 7.36%1-methyl and 2-heptanone, 3-methyl. 
However, 4,5-Diaminobenzofurazan not reported previously in M. peregirna plant 
extracts.  
In acetone extract of M. peregrina, only ten compounds were identified by 
GC-MS.  Among that 3-methyl-3-butenyl - Benzene was the predominant molecule 
with highest percentage (24.95%). But this compound not reported previously in M. 
peregrina and also in other plant species.  In the meantime, one of the major 
compounds in acetone extract of M. peregrina root tubers, Hexamethyl-
Cyclotrisiloxane was reported in many plants. GC-MS analysis of Solanum villosum 
leaves revealed that the presence of Hexamethyl-Cyclotrisiloxane with 2.12% 
(Venkatesh et al., 2014). The presence of this compound in leaf ethyl acetate extract 
of Acacia karoo (Priyanka et al., 2015). Babu et al. (2017) reported the presence of 
Hexamethyl-Cyclotrisiloxane in Ficus arnottiana leaf chloroform extract. The 
compound also studied for its biological activity.  the authors reported no activity. 






acuminate (Krishna et al., 2015) and essential oils of Sedum pallidum (Dahpour et 
al., 2012). 
Previously, leaves, bark, and seeds of M. peregrina were reported for its 
phytochemical analysis. The dried leaves of M. peregrina were reported for the 
quantification of total phenol content (Safaeian et al., 2015). Aqueous and methanol 
extracts of leaves were investigated for phenol and flavonoid contents (El-Awady et 
al., 2016; Azim et al., 2017)). Also, Marwah et al. (2007) and Elabd et al. (2017) 
reported the phenol content of bark and seed oils. The occurrence of oleic acid-3 
hydroxy propyl ester was reported in oily aqueous seed extract of M. peregrina (Saleh 
et al., 2017). However, the root tubers were studied for phytochemical analysis for the 
first time. The GC-MS analyses of methanol extract of root tubers M. peregrina 
showed that the presence of 24 compounds account about cent percent of the extract. 
The major chemical composition of the extract was 4-hydroxy- Benzeneacetonitrile 
with the percentage of 12.09. This compound was not deducted in M. peregrina plant 
parts in earlier studies. However, 4-hydroxy- Benzeneacetonitrile was reported in 
Moringa oleifera extracts. Mathur and Kamal (2012) studied the phytochemical 
composition of pods of Moringa oleifera by GC-MS and authors deducted 3.16% of 4-
hydroxy- Benzeneacetonitrile. Vats and Gupta (2017) deducted very less amount 
(0.24%) of 4-hydroxy- Benzeneacetonitrile in hydroethanolic extract of Moringa 
oleifera. Hence, the results on phytochemical screening on the present study indicated 
that the availability of phytochemicals is based on different factors such as the 
geographical location, maturity of plants, solvents used for the extraction etc.    
Plant derived molecules are prosperous sustainable resources for new drugs 






compounds analysed by GC-MS were studied for its pharmacological activities 
(Kumar et al., 2010; Sermakkani and Thangapandian, 2012; Ezhilan and 
Neelamegam, 2012; Kumar et al., 2014; Ravisankar and Ester, 2017). In the present 
study, hexane, chloroform, acetone and methanol extracts of M. peregrina root tubes 
were screened for anticancer activity against human breast cancer cell line (MCF-7). 
The cell line was treated with different concentrations viz. 10,20,40,80,160 and 320 
µg/ml plant extracts and the results were compared with the standard drug 
Doxorubicin. All the four extracts were inhibited the breast cancer cells at the 
maximum concentration of 320 µg/ml. However, the highest activity was noted in 
chloroform extract. This result is in accordance with previous studies.  
Al-Oqail et al. (2015) reported the anticancer activity of chloroform extract 
of Nepeta deflersiana along with various sub fractions of the plant against human 
breast cancer (MCF-7) and human lung cancer cell lines (A-549). It was found that 
the chloroform extract and its sub fraction reduced the cell viability of the both the 
cells significantly in a concentration dependent manner. Dried leaf chloroform 
extract of Rinum amabile were reported for the ant proliferative effect on different 
cell lines viz. breast carcinoma with estrogen receptor (MCF-7), breast carcinoma 
without estrogen receptor (MDA-MB-23), colon adenocarcinoma (HT-29), acute 
lymphoma leukemia (Reh) and colon carcinoma (HCT-16) (Lim et al., 2019).The 
authors reported that the chloroform extract showed concentration depended 
cytotoxic effect on all the cell lines tested. Similarly, chloroform extract of 
Polygonatum verticillatum rhizomes was investigated for the anticancer activity 
against MCF-7 cell lines with different concentrations ranging from 25 to 400 μg/mL 
and the extract showed good anticancer activity (Singh and Patra, 2018). In the 






associated with the chemical compounds which dissolved in non-polar solvent such 
as chloroform. Furthermore, it is believed that the synergistic effect of phytochemical 
present in the extract is responsible for the biological activity.  
In 2011, Shang et al. reported the anticancer activity of Taxus cuspidate 
extracts and its synergistic effect with 5-FU. The experiment was performed on 
breast, lung, gastric, prostate, melanoma, hepatocellular, oral squamous, cervical, 
leukemic, mouse spleen T and B lymphocytes, human embryonic lung and normal 
cell lines. The synergistic effect study showed it was effective in cancer cell line and 
had lower cytotoxicity in normal human cell. A study was executed to find the 
synergetic anticancer potential of Berberine and Curcumin on human cancer cell 
lines MCF-7, Hep-G2, A549, K562 and Jurkat. The estimation of inhibition of the 
cell proliferation showed that synergetic anticancer potential of Berberine combained 
with Curcumin showed greater cell death percentage compared to pure compounds 
tested. There is no evidence of the hexylene glycol have the anti-cancerous 
properties, present major percentage in the chloroform extract, but the benzofurazan, 
the next highest percentage compound are reported with anti-cancerous properties. 
The presence of ethylene glycol may be synergized the cytotoxic effect of 
benzofurazan on cancer cells.  Chloroform extract showed highest anti cancer 
activities and GC-MS analysis showed traces of different compounds in the extract.  
The acetone and methanol extracts of M. peregrina root tubers showed less anticancer 
activity even though the acetone extracts contain benzylisoquinoline alkaloid as the 
major compound. This structurally diverse group metabolite is long history of study 
and it has already exploited for its medicinal properties. However, ecophysiological 







Chapter 5: Conclusion 
 
Natural products are the ideal candidates for the discovery and development of 
novel drugs. Nowadays, plant derived compounds gained attention to have significant 
importance in the treatment of a wide range of diseases including cancers. It is due to 
the efficiency, lesser/no side effects, easy availability and cost-effectivity. 
Phytochemicals such as tannins, flavonoids and Polyphenolic compounds showed 
anticancer activity on different cell lines through various mechanisms. In the present 
study, hexane, chloroform, acetone and methanol extracts of M. peregrina were 
screened for phytochemical analysis and anticancer activity. Phytochemical analysis 
was performed by Gas Chromatography and Mass spectrometry (GC-MS). The 
anticancer potential of the extracts was done on the human breast cancer cell line 
(MCF-7) and cell viability was measured using WST-1 Cell Proliferation Assay Kit. 
The cell line was treated with different concentrations (10, 20, 40, 80, 160 and 320 
µg/ml) of plant extracts and the results were compared with the standard drug 
Doxorubicin. The results of GC-MS analysis of hexane extract revealed that a total of 
33 compounds were identified and the major compounds was β-Sitosterol (16.90%), 
Stigmasterol (12.36%), 24-methyl- 5-Cholestene-3-ol (11.83%), cis-10-Heptadecenoic 
acid (10.85%), n-Hexadecanoic acid (8.95%), cis-Vaccenic acid (8.5%), Methyl cis, cis-
9,12-octadecadienoate (5.20%), 8-Octadecenoic acid methyl ester (5.09%), 4-methyl-
methyl ester Pentadecanoic acid (4.66%), (3β)- 9,19-Cyclolanostan-3-ol, 24-methylene 
(1.91%), Oleic Acid (1.70%) and 9-Octadecenoic acid (Z) Methyl ester (1.46%). 
Chloroform extract of M. peregrina tubers contains fifty compounds among that 
Hexylene glycol (36.35%) and 4,5-Diaminobenzofurazan (12.59%) N-(phenylmethyl)- 






Benzylformamide (3.72%),  9-Hexacosene (3.18%), 1-(phenyl-methyl)- 3-Pyrrolidinone 
(2.38%) and (Z)-13-Octadecenal (2.27%) were identified as prominent chemical 
compounds. In acetone extract, 3-methyl-3-butenyl)- Benzene (24.95%), 1-
Benzylazetidine (18.24%), cis-13-Octadecenoic acid (15.89%), followed by 1-
benzyltetrahydroisoquinoline (11.04%),  2,4,6-Cycloheptatrien-1-one, 3,5-b is-
trimethylsilyl (6.52%), 1-methyl- 4-Piperidinemethanol (5.86%),  E,Z-2,13-Octa-
decadien-1-ol (5.56%). In methanol extract, 4-hydroxy- Benzeneacetonitrile was 
identified as a major compound among the compounds representing about 12.09% of the 
total extract. Moreover, l-Valine, N-benzyloxycarbonyl-decyl ester (9.96%), Phenyl 
cyanide (9.8%), Benzoic acid (9.13%), 2-Benzyloxyethyl chloroformate (7.03%), 
Benzeneacetamide (6.55%), 2,4-dihydroxy-Benzaldehyde (6.48%), 4-Benzylamino-1-
methylcytosine (5.86%), cis-13-Octadecenoic acid (4.77%), Benzeneacetic acid 
(4.56%), 2,2,6,6-tetramethyl-4-Piperidinone (4.39%) also identified as major 
compounds. The anticancer activity revealed that the chloroform extract of M. 
peregrina showed good activity against the human breast cancer cell line with the IC50 
value of 127.38 µg/ml. The IC50 values of hexane, acetone and methanol extracts were 
315.0, 284.8 and 353.10 µg/ml respectively. Whereas the IC50 value of the standard 
drug, Doxorubicin was 25.88 µg/ml. The present study shows that the chloroform 
extract of M. peregrina root tubers showed good anticancer activity and it could be 
used further for the isolation and characterization of new anticancer molecules. Since 
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